Stress not linked to breast cancer relapseJune 12, 2002Women with breast cancer need not fear that stressful experiences in life will bring about the return of their disease, conclude researchers in this week’s BMJ. The study involved 222 women, aged under 60, who had been diagnosed with a primary operable breast tumour between May 1991 and July 1994. The team collected data on stressful life experiences and depression from 12 months before diagnosis to five years afterwards. Biological factors known to influence prognosis of breast cancer were also taken into account. They found no evidence that women who have a severely stressful life experience in the year before being diagnosed with breast cancer, or in the five years afterwards, are at any increased risk of developing a recurrence of their disease. In fact, women who had one or more severely stressful life experiences after diagnosis had a lower risk of recurrence than those who did not. These findings contradict an earlier study that showed severely stressful life experiences increase the risk of recurrence of breast cancer, say the authors. However, different study methods may explain the contradictory results. “We took the prospective study as the more robust, and the results suggest that women with breast cancer need not fear that stressful experiences will precipitate the return of their disease,” they conclude. British Medical Journal (BMJ) |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles New figures on cancer in Europe show a steady decline in mortality but big variations New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union (EU) between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population. Elastography reduces unnecessary breast biopsies Elastography is an effective, convenient technique that, when added to breast ultrasound, helps distinguish cancerous breast lesions from benign results, according to an ongoing study presented today at the annual meeting of the Radiological Society of North America (RSNA). First live targeting of tumors with RNA-based technology Finding and treating a tumor without disturbing normal tissue presents challenges - sometimes the most effective therapies can be invasive and harsh. Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||